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Due to unique properties and unlimited possible applications, graphene has attracted abundant interest in the
areas of nanobiotechnology. Recently, much work has focused on the synthesis and properties of graphene. Here
we show that a successful reduction of graphene oxide (GO) using spinach leaf extract (SLE) as a simultaneous
reducing and stabilizing agent. The as-prepared SLE-reduced graphene oxide (S-rGO) was characterized by
ultraviolet–visible spectroscopy and Fourier transform infrared spectroscopy. Dynamic light scattering technique
was used to determine the average size of GO and S-rGO. Scanning electron microscopy and atomic force
microscopy images provide clear surface morphological evidence for the formation of graphene. The resulting
S-rGO has a mostly single-layer structure, is stable, and has significant water solubility. In addition, the
biocompatibility of graphene was investigated using cell viability, leakage of lactate dehydrogenase and alkaline
phosphatase activity in primary mouse embryonic fibroblast (PMEFs) cells. The results suggest that the biologically
synthesized graphene has significant biocompatibility with PMEF cells, even at a higher concentration of 100 μg/mL.
This method uses a ‘green’, natural reductant and is free of additional stabilizing reagents; therefore, it is an
environmentally friendly, simple, and cost-effective method for the fabrication of soluble graphene. This study could
open up a promising view for substitution of hydrazine by a safe, biocompatible, and powerful reduction for the
efficient deoxygenation of GO, especially in large-scale production and potential biomedical applications.
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Recently, carbon-based nanomaterials such as carbon
nanotubes, graphene oxide, and graphene have been ex-
plored extensively by researchers as well as the industry.
Graphene is an emerging nanomaterial which has greater
scientific and commercial advantages. Recently, single-
layer and few-layer graphenes received great interest due
to its exceptional characteristics including high surface
area as well as strong electronic, mechanical, thermal, and
chemical properties in various fields such as materials
science, physics, chemistry, biotechnology, and nanome-
dicine [1-3]. Particularly, graphene has been attracted to
the scientific community for numerous potential applications* Correspondence: gsangiliyandi@yahoo.com; jhkim541@konkuk.ac.kr
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reproduction in any medium, provided the origin biotechnology, including biosensing [4,5], disease diag-
nostics [6], antibacterial [7-11] and antiviral materials [12],
cancer-targeting [13] and photothermal therapy [14,15],
drug delivery [16-18], and tissue engineering [19,20] due
to these unique physical, chemical, and biocompatibility
properties. During the past few years, several procedures
have been established for the synthesis of graphene and
its derivatives, including mechanical exfoliation, epitaxial
growth, unzipping carbon nanotubes, exfoliation of GO,
and liquid-phase exfoliation of graphite [21]. Moreover,
several other methods were implemented to prepare high-
quality graphene such as chemical vapor deposition onto
thin films of metal, epitaxial growth on electrically insulat-
ing surfaces like silicon carbide, and the scotch tape
method [21]. All of these methods can produce highly crys-
talline graphene but are not suitable for mass productionis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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vironmentally friendly and green approach including flash
photo reduction [24] hydrothermal dehydration [22],
solvothermal reduction [23], and catalytic [25] and photo-
catalytic reduction [26]. The most promising method for
the large-scale production of graphene is the chemical oxi-
dation of graphite, conversion of the resulting graphite
oxide to GO, and subsequent reduction of GO. The exfoli-
ation of GO is one of the well-established methods for the
mass production of graphene in the presence of some
chemical reducing agents such as hydrazine and sodium
borohydride [27,28]. The usage of strong chemical redu-
cing agents such as hydrazine is found to be corrosive,
highly explosive, and highly toxic [29]. In addition, hydra-
zine seems to be a hepatotoxic and carcinogenic agent in
the kidney, and liver damage can result in blood abnor-
malities, irreversible deterioration of the nervous system,
and even DNA damage [30]. In this context, many studies
used the green chemistry approach for the reduction of
GO to overcome the toxicity problem using various bio-
logical molecules as reducing agents such as vitamin C
[31], melatonin [32], sugars [33], polyphenols of green tea
[34,35], bovine serum albumin [36], and biomass of bacteria
[37,38]. The biologically derived graphene nanomaterials
are biocompatible, stable, and soluble.
Biocompatibility is an essential factor for tissue engineer-
ing applications. Recent studies suggest that the biocom-
patibility of carbon-based nanomaterials depends strongly
on mass, purity, ratio, and surface functional groups. A
variety of biological applications depend on the functiona-
lization of graphene. The ability of the functionalization of
graphene and its derivatives brought the attention of
nanomaterials in various applications including biosensors
and tissue engineering. Several studies have reported the
biocompatibility of graphene derivatives in proximity of
mammalian cells. Biris et al. [39] demonstrated that osteo-
blast cells (MC3T3-E1) have a high ability to grow on
graphene film. Agarwal et al. [19] reported that reduced
graphene oxide (rGO) is more biocompatible than single-
wall carbon nanotubes using different cell lines including
neuroendocrine PC12 cells, oligodendroglia, or osteoblasts.
Recently, Gurunathan and coworkers reported that
microbially reduced graphene oxide shows significant bio-
compatibility with primary mouse embryonic fibroblast
(PMEF) cells. Chen et al. [40] cultured PC12 cells with car-
bon nanotubes and rGO films with the same initial seeding
density for 5 days, and the results suggest that the cells
cultured with rGO enhanced proliferation, whereas
nanotubes inhibited the proliferation of cells. Nayak et al.
[41] reported that G-coated substrates accelerated osteo-
genic differentiation of human mesenchymal stem cells
(hMSCs) compared to uncoated substrates. Lee et al. [42]
reported that GO films enhanced adipogenesis of hMSCs
due to their high affinity with insulin. Chen et al. [43]reported that G-coated substrates maintained induced
pluripotent stem cells in the undifferentiated state.
Regarding synthesis of nanomaterials, various phyto-
chemicals have been used from different natural sources
like leaves, peels, roots, seeds, and other parts of plants
as reducing agents for the synthesis of different metal
nanoparticles like silver and gold [44-47]. Here we
attempted to use spinach leaves because it is nontoxic
and an edible plant which has high nutritional value
and is extremely rich in antioxidants; therefore, the leaf
extracts of spinach could be potential alternative redu-
cing agents for the synthesis of soluble graphene. In the
present report, we investigated a greener approach for
the reduction of GO using spinach leaf extracts (SLE),
and also we analyzed the biocompatibility effect of SLE-
reduced graphene oxide (S-rGO) in PMEFs.Methods
Chemicals
Graphite powder was purchased from Sigma-Aldrich
(St. Louis, MO, USA). NaOH, KMnO4, anhydrous etha-
nol, 98% H2SO4, 36% HCl, and 30% hydrogen peroxide
aqueous solution were purchased from Sigma-Aldrich
(USA) and used directly without further purification. All
aqueous solutions were prepared with deionized (DI)
water. All other chemicals were purchased from Sigma-
Aldrich (St Louis, MO, USA) unless stated otherwise.
Spinach leaves were obtained from the local market
and stored at 4°C until needed. Twenty grams of spinach
leaves was washed thoroughly with double distilled water
and was then sliced with a sharp stainless steel knife into
fine pieces, about 1 to 5 cm2. The finely cut spinach
leaves were mixed in 100 mL of sterile distilled water
and then boiled for 2 min. After boiling, it was filtered
through Whatman filter paper no. 1. Further, the ex-
tracts were used for synthesis of graphene. The extracts
were stored at 4°C until further use.Synthesis of GO
Natural graphite powder was utilized as the raw material
to prepare graphite oxide by suspension through a modi-
fied Hummers’ method [48] and according to Esfandiar
et al. [32]. The prepared graphite oxide powder was dis-
persed in DI water to obtain an aqueous graphite oxide
suspension with a yellow-brownish color. The suspen-
sion was centrifuged at 3,000 rpm/min for 10 min to
eliminate unexfoliated graphitic plates and then at
10,000 rpm/min for 10 min to remove tiny graphite par-
ticles. Finally, a GO suspension was achieved by exfoli-
ation of the filtered graphite oxide suspension through
its sonication. Reduction of graphene oxide was followed
as described earlier [38] with slight modification.
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Reduced graphene oxide was obtained from the reaction
of a plant extract with graphene oxide. In the typical re-
duction experiment, 10 mL of spinach leaf extract was
added to 40 mL of 0.5 mg/mL aqueous GO solution and
then the mixture was kept in a tightly sealed glass bottle
and stirred at 30°C for 24 h. Then, using a magneto-
stirrer heater, reduced graphene oxide suspension was
stirred at 400 rpm at a temperature of 30°C for 30 min.
A homogeneous S-rGO suspension was obtained with-
out aggregation. Then, the functionalized S-rGO was fil-
tered and washed with DI water. Finally, a black S-rGO
dispersion was obtained.
Characterization
Ultraviolet–visible (UV–vis) spectra were obtained using
a WPA (Biowave II, Biochrom Cambridge, UK). The
aqueous suspension of GO and S-rGO was used as UV–
vis samples, and deionized water was used as the refer-
ence. The particle size of dispersions was measured by
Zetasizer Nano ZS90 (Malvern Instruments Limited,
Malvern, UK). X-ray diffraction (XRD) analyses were
carried out on an X-ray diffractometer (Bruker D8 DIS-
COVER, Bruker AXS GmBH, Karlsruhe, Germany). The
high-resolution XRD patterns were measured at 3 kW with
Cu target using a scintillation counter, and λ = 1.5406 A at
40 kV and 40 mA was recorded in the range of 2θ = 5° −
80°. The changes in the surface chemical bonding and
surface composition were characterized using a Fourier
transform infrared spectroscopy (FTIR) instrument
(PerkinElmer Spectroscopy GX, Branford, CT, USA). A
JSM-6700F semi-in-lens FE-SEM operating at 10 kV
was used to acquire SEM images. The solid samples
were transferred to a carbon tape held by an SEM sam-
ple holder for analyses. The analyses of the samples
were carried out at an average working distance of 6
mm. Raman spectra of graphene oxide and reduced
graphene oxide were measured by WITec Alpha300
(Ulm, Germany) with a 532-nm laser. The calibration
was initially made using an internal silicon reference at
500 cm−1 and gave a peak position resolution of less
than 1 cm−1. The spectra were measured from 500 to
4,500 cm−1. All samples were deposited on glass slides
in powder form without using any solvent. Surface images
were measured using tapping-mode atomic force micros-
copy (SPA 400, SEIKO Instruments, Chiba, Japan) operat-
ing at room temperature. Height and phase images were
recorded simultaneously using nanoprobe cantilevers
(SI-DF20, SEIKO Instruments).
Exposing PMEFs to GO and S-rGO
PMEF cells were routinely cultured in Dulbecco’s modified
Eagle’s low-glucose medium (DMEM/low, Gibco BRL Life
Technologies, Grand Island, NY, USA) supplemented with10% (v/v) fetal bovine serum, plus 2 mM of L-glutamine,
and 1% (v/v) penicillin-streptomycin (10 U mL−1 penicillin
and 0.1 mg mL−1 streptomycin) and grown at 37°C in a
5% CO2 humidified environment. When the cells had
reached 70% confluence, they were trypsinized (0.25%
trypsin and 0.04% EDTA, Sigma-Aldrich) and passaged
(1:3). Cells within three passages were used for experi-
ments. GO or S-rGO suspensions were freshly prepared
before the cells were exposed and diluted to appropriate
concentrations from 20 to 100 μg mL−1 with the culture
medium; they were then immediately applied to the cells.
DMEM without GO and S-rGO supplements served as a
negative control in each experiment.
Cell viability assay
WST-8 assay was followed as described earlier by Liao
et al. [49]. Typically, 1 × 104 cells were seeded in a 96-
well plate and cultured in DMEM supplemented with
10% at 37°C under 5% CO2. After 24 h, the cells were
washed with 100 μL of serum-free DMEM two times
and incubated with 100 μL of different concentrations of
GO or S-rGO suspensions in serum-free DMEM. After
a 24-h exposure, the cells were washed twice with
serum-free DMEM, and 15 μL of WST-8 solution was
added to each well containing 100 μL of serum-free
DMEM. After 1 h of incubation at 37°C under 5% CO2,
80 μL of the mixture was transferred to another 96-well
plate because residual GO or S-rGO can affect the
absorbance values at 450 nm. The absorbance of the
mixture solutions was measured at 450 nm using a
microplate reader. Cell-free control experiments were
performed to see if GO and rGO react directly with
WST-8 reagents. Typically, 100 μL of GO or S-rGO sus-
pensions with different concentrations (20 to 100 μg/mL)
was added to a 96-well plate and 10 μL of WST-8 reagent
solution was added to each well; the mixture solution was
incubated at 37°C under 5% CO2 for 1 h. After incubation,
GO or S-rGO was centrifuged and 50 μL of the super-
natant was transferred to another 96-well plate. The op-
tical density was measured at 450 nm.
LDH assay
Cell membrane integrity of PMEF cells was evaluated by
determining the activity of lactate dehydrogenase (LDH)
leaking out of the cell according to manufacturer’s in-
structions (in vitro toxicology assay kit, TOX7, Sigma-
Aldrich). The LDH assay is based on the release of the
cytosolic enzyme, LDH, from cells with damaged cellular
membranes. Thus, in cell culture, the course of GO- and
S-rGO-induced cytotoxicity was followed quantitatively
by measuring the activity of LDH in the supernatant.
Briefly, cells were exposed to various concentrations of
GO and S-rGO for 24 h, and then 100 μL per well of
each cell-free supernatant was transferred in triplicates
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reaction mixture was added to each well. After 3 h of in-
cubation under standard conditions, the optical density
of the color generated was determined at a wavelength
of 490 nm using a microplate reader.
Alkaline phosphatase activity
PMEF cells were cultured in a 48-well culture dish
at a density of 5 × 103 cells per well for 4 days. Then
medium was replaced with treatment solution, which
was DMEM containing 5% serum plus GO or S-rGO.
After 4 days, the alkaline-phosphatase activity was mea-
sured according to the method described by manufac-
turer’s instructions (DALP-250, QuantiChrom™ Alkaline
Phosphatase Assay Kit, Gentaur, Belgium). The plates
were incubated at 37°C for 30 min. The amount of re-
leased p-nitrophenol was measured at 405 nm in a 96-
well microplate reader. Enzyme activity was evaluated as
the amount of nitrophenol released through the enzym-
atic reaction, and absorbance was recorded using a
microplate reader (Bio-RAD 680, Hercules, CA, USA) at
405 nm. For normalization, the total protein content
was measured using a bicinchoninic acid protein assay
kit. Thus, the alkaline phosphatase (ALP) activity was
expressed and normalized by the total protein content
(U/mg).
Results and discussion
Reduction of GO by SLE
Reduction of GO was carried out at room temperature
using spinach leaf extract. On completion of the reduc-
tion process, the color change from brown to black pro-
vides the soluble reduced product (inset of the Figure 1).
This preliminary experiment suggested that spinach leaf
extracts have the ability to remove oxygen-containingFigure 1 UV–vis absorption spectra of SLE, GO, and S-rGO suspensionmoieties present in GO, which is the piece of evidence
for reduction process. Further, the spectra of GO and S-
rGO were recorded using UV–vis absorption spectros-
copy, which is a simple and valuable technique. GO shows
a maximum absorption peak at 231 nm which was attrib-
uted to the π-π* transitions of the aromatic C-C bonds
and a weak shoulder at 300 nm due to n-π* transitions of
C=O bonds. After complete reduction, a red shift of this
characteristic peak was observed at 265 nm for S-rGO
(Figure 1); this indicates that electronic conjugation was
restored. When SLE was used as control, it showed two
peaks at 450 and 650 nm, which are different from those
of GO and S-rGO. As GO had a light brownish color and
S-rGO a black color suspension, as we have expected, the
optical absorption of all S-rGO was higher than that of
GO. In agreement with our results, Thakur and Karak
observed a characteristics peak value at 268 nm using
phytoextracts for both Camellia sinensis peel aqueous
extract-reduced GO and Mesua ferrea leaf aqueous
extract-reduced GO [50].
XRD analysis
XRD is an effective technique to investigate the interlayer
changes and the crystalline nature of the synthesized
material. XRD patterns of GO and S-rGO are shown in
Figure 2. Pristine graphite exhibits a basal reflection
(002) peak at 2θ = 26.6° corresponding to a d spacing of
0.335 nm. Upon oxidation of pristine graphite, the (002)
reflection peak shifts to a lower angle at 2θ = 11.7,
(d spacing = 0.76 nm). The increase in d spacing is due to
the intercalation of water molecules and the formation of
oxygen-containing functional groups between the layers
of the graphite [51]. In contrast with GO, S-rGO shows a
broad peak centered at 2θ = 26.4° corresponding to a d
spacing of 0.36 nm which may be due to the restacking ofs in water.
Figure 2 XRD patterns of GO (A) and S-rGO (B).
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of graphite oxide and the appearance of a broad band at
2θ = 26.4° in the S-rGOs indicate the formation of few-
layer graphene, which are close to that of pristine
graphene nanosheets (26.6°), revealing the reduction of
graphene oxide by spinach leaf extract. These XRD results
suggest that spinach leaf extracts are capable in reducing
GO and in removing intercalated water molecules and
oxide groups in GO.
DLS analysis
We employed dynamic light scattering (DLS) technique
to elucidate the status of GO and S-rGO sheets in aque-
ous solution. DLS measurement was performed in aque-
ous solution to elucidate the size of reduced graphene
oxide after reaction with GO. It was found that the aver-
age hydrodynamic diameter (AHD) of GO was 2,000 ±
50 nm (Figure 3). However, after the reduction of GO
with spinach leaf extract, an AHD of 3,000 ± 70 nm was
obtained under the same instrumental conditions, which
was relatively higher than that of GO. This noticeable
change in size distribution indicated that SLE not only
acted as a reducing agent to prepare rGO but also was
functionalized on the surfaces of the resulting rGO, lead-
ing to an increased size. Stankovich et al. [27] reported
that functionalized graphene nanoplates treated withisocyanate show an AHD of 560 ± 60 nm, which is not
their average dimension but rather the effective hydro-
dynamic diameter of an equivalent sphere described by
the tumbling of the platelets. Wang et al. [52] reported
similar observations using heparin as a reducing agent,
and they found that the average sizes of GO and rGO
were 302.5 and 392.4 nm, respectively, under the same
instrumental conditions, which were relatively larger
than that of GO. Liu and coworkers [53] reported that
the size of various graphene materials such as Gt, GtO,
GO, and rGO dispersions are 5.25, 4.42, 0.56, and 2.93
μm, respectively, and the increasing size could be the ag-
gregation of rGO fragments. The DLS results only show
the size differences between GO and rGO [53]. In order
to confirm further sizes, the dispersions were further
dropped on aluminum foil and dozens of SEM images
were taken randomly for each sample.
FTIR analysis
FTIR is a valuable technique to prove the degree of GO
reduction. Figure 4 shows FTIR spectra of GO and S-
rGO; the characteristic peaks of GO, including O-H
stretching at 3,400 cm−1, C-O stretching at 1,720 cm−1,
skeletal vibration of unoxidized graphitic domains at
1,620 cm−1, O-H deformation at 1,400 cm−1, C-OH
stretching at 1,220 cm−1, and C-O stretching at 1,030 cm−1,
Figure 3 Hydrodynamic size distribution of GO (A) and S-rGO (B).
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[34,50,51]. As shown in Figure 4, GO has very strong peaks
at 3,419 cm−1 (O-H) attributed to the water molecules. For
the S-rGO sample, the intensities of the bands associated
with the oxygen functional groups strongly decreased in re-
lation to those of GO. The results indicate that graphite is
successfully oxidized and probably cleaved in the form
of GO. GO has two new peaks at 1,720 cm−1 (C=O) fromFigure 4 FTIR spectra of GO and S-rGO.carbonyl and carboxylic groups and at 1,050-cm−1 (C-O)
peak from carbonyl, carboxylic, and epoxy groups, which
confirms the presence of oxygen-containing functional
groups. The peak at 1,625 cm−1 indicates the restoration
of sp2. The peak at 1,720 cm−1 almost disappeared in
S-rGO because of the removal of C=O. While being re-
duced by the extract of leaf, the peaks for oxygen func-
tional groups at 3,400 cm−1 significantly decreased. These
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in the GO were removed [34,50,51]. The FTIR spectrum
of S-rGO indicates a significant reduction of the intensity
of all oxygen-containing moieties suggesting an efficient
conversion of GO to graphene by the leaf extract of spin-
ach. The obtained results are comparable with earlier re-
port that used various reducing agents for deoxygenation
of GO such as sugar [33], tea polyphenol [34,35], and
phytoextract [50].
SEM analysis
The dispersions of GO and S-rGO were further analyzed
using SEM. Images were taken randomly from each
sample. GO sheets were prepared from natural Gt flakes
and had significant solubility in water because of their
plentiful oxygen-containing functional groups [54-58]. In
general, Gt appears to be piled up with thick cakes,
while GO is exfoliated into thin large flakes with wavy
wrinkles. The functionalized graphene nanosheets
(f-GNs) are mostly wrinkled flakes that are similar to
GO, but for the f-GNs functionalized with long chains
and polymers, the surfaces are coarse and hairy and the
edges of the flakes are blurry [54]. At higher concentra-
tions, the surfaces of GO sheets have a soft-carpet-like
morphology, which may be due to residual H2O mole-
cules and hydroxyl/carboxyl groups attached to GO [58].
As shown in Figure 5A, GO sheets are smooth with
small wrinkles at the edges and also look wavy in nature.
The SEM images of GO samples resemble transparent
and rippled silk waves. The edges of the exfoliated GO
sheets are crumpled due to the oxidation process,
whereas S-rGO has a wrinkled paper-like morphology
with a sheet-like structure (Figure 5B). As a result of in-
creased levels of oxidation, a significant change was ob-
served at the sharp edges. This difference in morphology
between the folded stacked structure of GO and theFigure 5 SEM images of GO (A) and S-rGO (B).folded structures for reduced GO implies that the spin-
ach leaf extract reduction process plays a significant role
in this transformation of GO to graphene.
Raman spectroscopy study
Raman spectroscopy is an effective tool to characterize
graphite and graphene materials, which strongly depend
on the electronic structure. As shown in Figure 6A, the
Raman spectrum of GO was found to significantly
change after the reduction. In the spectra of GO and S-
rGO, two fundamental vibration bands were observed in
the range of 1,300 to 1,700 cm−1. The G vibration mode,
owing to the first-order scattering of E2g phonons by sp
2
carbon of GO and S-rGO, were at 1,611 and 1,603 cm−1,
respectively, while the D vibration band obtained from a
breathing mode of k-point photons of A1g symmetry of
GO and S-rGO appeared at 1,359 and 1,342 cm−1,
respectively (Figure 6A,B) [27-29]. After the reduction of
GO, the intensity ratio of the D band to the G band (ID/IG)
was increased significantly, which indicates the introduc-
tion of sp3 defects after functionalization and incomplete
recovery of the structure of graphene [59]. As the D band
arises due to sp2 carbon cluster, a higher intensity of D
band suggested the presence of a more isolated graphene
domain in S-rGO compare to GO and that SLE is able to
remove oxygen moieties from GO. Wang et al. [60] sug-
gested that the G band is broadened and shifted upward
to 1,595 cm−1, and increasing the intensity of the D band
at 1,350 cm−1 could be attributed to the significant de-
crease of the size of the in-plane sp2 domains due to oxi-
dation and ultrasonic exfoliation and partially ordered
graphite crystal structure of graphene nanosheets. The Ra-
man spectra of graphene-based materials also show a two-
dimensional (2D) band which is sensitive to the stacking
of graphene sheets. It is well known that the two-phonon
(2D) Raman scattering of graphene-based materials is a
Figure 6 Raman spectra of GO (A) and S-rGO (B).
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from multilayer graphene as it is highly perceptive to the
stacking of graphene layers [27-29]. Generally, a Lorentzian
peak for the 2D band of the monolayer graphene sheets is
observed at 2,679 cm−1, whereas this peak is broadened
and shifted to a higher wave number in the case of multi-
layer graphene [27-29]. In this investigation, 2D bands
were observed at 2,690 and 2,703 cm−1 for GO and S-
rGO, respectively. The results of the Raman spectrum are
in good agreement with those of previous studies in which
using aqueous leaf extracts of Colocasia esculenta and M.
ferrea Linn, an aqueous peel extract of orange [50]. Re-
duced with wild carrot root, the G band of GO is broad-
ened and shifted to 1,593 cm−1, while the D band is
shifted to a lower region (1,346 cm−1) and becomes more
prominent, indicating the destruction of the sp2 character
and the formation of defects in the sheets due to extensive
oxidation [51]. This observation is in good agreement with
previous studies and supports the formation of functional-
ized graphene using various biological systems such as
baker’s yeast [61], sugar [29,34], and bacterial biomass
[38].
AFM study
Atomic force microscopy (AFM) is an important tech-
nique for the morphological characterization of GO and
graphene materials and is also capable of imaging and
evaluating the surface morphology and properties [54-58].
Figure 7A,B is a typical AFM image of GO and graphene
dispersion in water after their deposition on a freshly
cleaned glass surface. The average thickness of as-
prepared graphene, measured from the height profile of
the AFM image, is about 23.81 nm. Compared with the
well-exfoliated GO sheets, with a thickness of about
8.09 nm (Figure 7A), the thickness of graphene is larger
than that of GO (Figure 7B). The height profile diagramof the AFM image indicates that the thickness of the
sheets is around 23.81 nm, comparable to the typical
thickness of single-layer GO sheets (8.09 nm). Akhavan
et al. [29] used glucose as a reducing agent for the syn-
thesis of graphene and suggested that the increase in
thickness of the reduced sheets can be assigned to ad-
sorption of reductant molecules such as glucose-based
molecules on both sides of the reduced sheets. Esfandiar
et al. [32] observed increased thickness of graphene due
to the attachment of the oxidized melatonin molecules
on both sides of the reduced GO. Similarly, Zhu et al.
[33] suggested that the capping reagent plays an import-
ant role in increasing the thickness of the as-prepared
GNS, though most of the oxygen-containing functional
groups were removed after the reduction. Su et al. [62]
demonstrated that dispersed molecules with large aromatic
structures and extra negative charges are noncovalently
immobilized on the basal plane of graphene sheets via
strong interactions.
Biocompatibility of S-rGO
Measuring the biocompatibility of graphene is complex
and depends on the techniques used for synthesis and
the selection of the biological model system for study.
In order to evaluate the biocompatibility of as-prepared
S-rGO, the cytotoxic effect of GO and S-rGO against
PMEF cells was investigated. As shown in Figure 8, the
viability of PMEF cells which were incubated with S-rGO
was always around 100% under the used concentrations
(10 to 100 μg/mL) after a 24-h exposure. This result indi-
cated that S-rGO was significantly biocompatible even if
relatively high concentrations were used; interestingly, cell
viability was not compromised when concentrations of
S-rGO were increased, whereas when concentrations of
GO were increased, the viability decreased to about 40%,
which was distinct to S-rGO. Taken together, these results
Figure 7 AFM images of GO (A) and S-rGO (B).
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is due to the functionalization of GO by spinach leaf ex-
tract. Previous studies demonstrated that hydrazine-rGO
was highly toxic to cells [7]. Therefore, it was considered
that the surface chemistry was the primary contributor toFigure 8 Effect of GO and S-rGO on cell viability of PMEF cells. Cell via
exposure to different concentrations of GO or S-rGO. The results represent
standard error of the mean. GO-treated groups showed statistically significathe difference of toxicity between S-rGO and GO. Several
studies have been reported in various cell types such as
lung epithelial cells, fibroblasts, and neural cells about the
interaction between graphene or GO sheets and cells
[11,63-66]. Single-layer GO sheets were internalized inbility of PMEF cells was determined using WST-8 assay after a 24-h
the means of three separate experiments, and error bars represent the
nt differences from the control group by Student’s t test (p < 0.05).
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epithelial cells or fibroblasts and induced toxicity at doses
above 20 μg/mL after 24 h [65]. Recently, Singh and co-
workers investigated amine-modified graphene on human
platelets, and they found that neither had no stimulatory
effect on human platelets nor did it induce pulmonary
thromboembolism in mice and suggested that G-NH2 is
the safest graphene derivative with potential for bio-
medical applications due to its lack of thrombotic and
hemolytic activities. Biocompatibility of graphene films
was compared with carbon nanotubes using a mouse
fibroblast cell line (L-929) to assess the cytotoxicity; the
results suggested that the cells adhered and proliferated
on graphene film well than carbon nanotubes, which indi-
cated that the material is biocompatible [67,68]. Akhavan
et al. [69] demonstrated that size and concentration are
dependent on the cytotoxicity and genotoxicity of gra-
phene oxide sheets and nanoplatelets in the hMSCs and
found that the reduced graphene oxide nanoplatelets
with average lateral dimensions of 11 nm exhibited a
strong potential in the destruction of the cells. The de-
struction of cells is due to contact interaction of the ex-
tremely sharp edges of graphene with the cells, and the
possible mechanisms could be oxidative stress which
eventually leads to DNA fragmentations and chromo-
somal aberrations. Furthermore, Akhavan et al. [70]
reported that the single-layer reduced graphene oxide
nanoribbons could penetrate into the cells and cause
DNA fragmentations as well as chromosomal aberra-
tions, even at a low concentration of 1.0 μg/mL after a
short exposure time of 1 h in hMSCs.Figure 9 Effect of GO and S-rGO on LDH leakage in PMEF cells. LDH le
reduction which were monitored at 490 nm, as described in the ‘Methods’
results represent the means of three separate experiments, and error bars r
statistically significant differences from the control group by Student’s t tesImpact of GO and S-rGO on membrane integrity
The reactive oxygen species (ROS) generated in a
concentration-dependent graphene is known as one of the
important mechanisms describing the cytotoxicity of
graphene [64]. Therefore, because we are interested to
evaluate the biocompatibility of GO and S-rGO on cell
membrane damage, LDH release (cell membrane damage
marker) was measured. As shown in Figure 9, a significant
LDH release was observed in the cells treated with GO
compared to the control group, and no obvious differ-
ences were observed even at higher concentrations of S-
rGO treated against the control group. However, distinct
increased LDH leakage was observed at higher concentra-
tions between 60 and 100 μg/mL of GO-treated cells.
Sasidharan et al. [71] reported that there was no LDH
leakage of Vero cells treated with both pristine and func-
tionalized graphene at different concentrations until 300
μg/mL. Recently, Zhang et al. [72] reported that cell cyto-
toxicity of dispersed nanographene platelets (NGPs)
exhibited dose-dependent characters, which had no obvi-
ous cytotoxic effects to MG63 cells at a concentration less
than 10 μg/mL, whereas it could delay cell cycle, promote
cell apoptosis, damage cell microstructure, induce serious
tumor necrosis factor-a expression, and greatly reduce
ALP activity of MG63 cells at higher concentrations of
NGPs. Zhang et al. [63] also reported that a few-layer
graphene increased intracellular generation of ROS and
induced mitochondrial injury in neural cells after 4 and 24
h at a dose of 10 μg/mL. In contrast, surface-modified
graphene and carboxylated graphene were reported to be
less toxic than GO or native graphene [73,74].akage was measured by changes in optical densities due to NAD+
section, using cytotoxicity detection lactate dehydrogenase kit. The
epresent the standard error of the mean. GO-treated groups showed
t (p < 0.05).
Figure 10 The effect of GO and S-rGO on alkaline phosphatase activity. PMEF cells were treated with various concentrations of GO and S-
rGO for 4 days. ALP activity was measured as described in the ‘Methods’ section. The results represent the means of three separate experiments,
and error bars represent the standard error of the mean. GO- and S-rGO-treated groups showed statistically significant differences from the
control group by Student’s t test (p < 0.05).
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ALP activity is an important and quantitative marker of
osteogenesis. Furthermore, ALP is an important marker
for functional activity of cells such as cell proliferation.
Cell numbers and ALP activity were used as measures of
cell proliferation, self-renewal, and pluripotency. ALP is
a membrane-bound enzyme that exhibits biphasic be-
havior. It is expressed on the surface of pluripotent un-
differentiated ES cells and disappears as cells begin to
differentiate. To examine cell differentiation, the ALP
was measured as a marker of differentiation. The ALP
activity was measured in GO- and S-RGO-treated cells,
and the results are represented in Figure 10. Alkaline
phosphatase activity was quantified by hydrolysis of
p-nitrophenyl phosphate after 4 days of treatment. As
expected, GO-treated cells showed a dose-dependent de-
crease of the alkaline phosphatase activity. The addition
of S-rGO significantly enhanced the alkaline phosphat-
ase activity above that of the control or GO-treated
groups. Aoki et al. [75] showed significant cell prolifera-
tion and ALP activity in single- and multiwall carbon
nanotube (CNT)-treated SaoS2 cells, and they suggest
that due to the structure and affinity of CNTs toward
proteins, CNTs could be the potential scaffold material
for tissue engineering. Zhang et al. [72] demonstrated
that cells cultured with NGPs at low concentrations have
a higher ALP expression close to the negative control
group.
Conclusions
We demonstrated a simple and green approach for the
synthesis of water-soluble graphene using spinach leafextracts. The transition of GO to graphene was con-
firmed by various analytical techniques such as UV–vis
spectroscopy, DLS, FTIR, SEM, and AFM. Raman spec-
troscopy studies confirmed that the removal of oxygen-
containing functional groups from the surface of GO led
to the formation of graphene with defects. The obtained
results suggest that this approach could provide an easy
technique to produce graphene in bulk quantity for gen-
erating graphene-based materials. In addition, SLE can
be used as an alternative reducing agent compared to
the widely used and highly toxic reducing agent called
hydrazine. Further, the cells treated with S-rGO show a
significant compatibility with PMEF cells in various as-
says such as cell viability, LDH leakage, and ALP activity.
The significance of our findings is due to the harmless
and effective reagent, SLE, which could replace hydra-
zine in the large-scale preparation of graphene. The
biocompatible properties of SLE-mediated graphene in
PMEFs could be an efficient platform for various biomed-
ical applications such as the delivery of anti-inflammatory
and water-insoluble anticancer drugs, and also it can be
used for efficient stem cell growth and differentiation
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